Alvotech

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Debiopharm Gets Global Rights To Repare

Alvotech is taking direct control of assembly and packaging services and boosting its vertical integration by agreeing to acquire Switzerland-based provider Ivers-Lee, the Icelandic firm’s former pref

Lupin and Zentiva have announced a license and supply agreement for the commercialization of Lupin’s Cimzia (certolizumab pegol) biosimilar “across multiple markets globally.” “Zentiva will oversee co

Fresh from declaring that it had received “very strong feedback” from global partners interested in licensing rights to new assets in the company’s pipeline, Alvotech has struck a fresh commercializat